A
Andrea Cipriani
Researcher at University of Oxford
Publications - 413
Citations - 30835
Andrea Cipriani is an academic researcher from University of Oxford. The author has contributed to research in topics: Randomized controlled trial & Meta-analysis. The author has an hindex of 64, co-authored 370 publications receiving 22792 citations. Previous affiliations of Andrea Cipriani include Oxford Health NHS Foundation Trust & World Health Organization.
Papers
More filters
Journal ArticleDOI
What is a randomised controlled trial
Andrea Cipriani,John R. Geddes +1 more
TL;DR: The Consolidated Statement of Reporting Trials (CONSORT) provides readers of RCTs with a list of criteria useful to assess trial validity (for full details visit www.consortstatement.org).
Journal ArticleDOI
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
Stefan Leucht,Andrea Cipriani,Andrea Cipriani,Loukia M. Spineli,Dimitris Mavridis,Deniz Örey,Franziska Richter,Myrto Samara,Corrado Barbui,Rolf R. Engel,John R. Geddes,Werner Kissling,Marko Paul Stapf,Bettina Lässig,Georgia Salanti,John M. Davis +15 more
TL;DR: A Bayesian-framework, multiple-treatments meta-analysis of randomised controlled trials to compare 15 antipsychotic drugs and placebo in the acute treatment of schizophrenia found all drugs were significantly more effective than placebo.
Journal ArticleDOI
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
Andrea Cipriani,Andrea Cipriani,Toshi A. Furukawa,Georgia Salanti,Anna Chaimani,Anna Chaimani,Anna Chaimani,Lauren Z Atkinson,Lauren Z Atkinson,Yusuke Ogawa,Stefan Leucht,Henricus G. Ruhé,Henricus G. Ruhé,Erick H. Turner,Julian P T Higgins,Matthias Egger,Nozomi Takeshima,Yu Hayasaka,Hissei Imai,Kiyomi Shinohara,Aran Tajika,John P. A. Ioannidis,John R. Geddes,John R. Geddes +23 more
TL;DR: This work aimed to update and expand previous work to compare and rank antidepressants for the acute treatment of adults with unipolar major depressive disorder, and found that all antidepressants were more effective than placebo.
Journal ArticleDOI
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
Andrea Cipriani,Andrea Cipriani,Toshiaki A. Furukawa,Georgia Salanti,John R. Geddes,Julian P T Higgins,Rachel Churchill,Norio Watanabe,Atsuo Nakagawa,Ichiro M Omori,Hugh McGuire,Michele Tansella,Corrado Barbui +12 more
TL;DR: Clinically important differences exist between commonly prescribed antidepressants for both efficacy and acceptability in favour of escitalopram and sertraline, which might be the best choice when starting treatment for moderate to severe major depression in adults.
Journal ArticleDOI
Imputing missing standard deviations in meta-analyses can provide accurate results.
Toshi A. Furukawa,Corrado Barbui,Andrea Cipriani,Paolo Brambilla,Norio Watanabe,Norio Watanabe +5 more
TL;DR: In this article, the authors compared the actual standardized mean difference (SMD) of individual RCTs and the meta-analytically pooled SMD of all randomized controlled trials (RCTs) against those based on the above-mentioned two imputation methods in two meta-analyses of antidepressants.